Deck 1: Sociocultural Aspects
Question
Question
Question
Question
Question
Question
Question
Question
Question
Question
Question
Question
Unlock Deck
Sign up to unlock the cards in this deck!
Unlock Deck
Unlock Deck
1/12
Play
Full screen (f)
Deck 1: Sociocultural Aspects
1
Which of the following health professionals can decrease the incidence of polypharmacy?
A) Medical practitioner
B) Pharmacist
C) Nurse
D) All of the above
A) Medical practitioner
B) Pharmacist
C) Nurse
D) All of the above
All of the above
2
In Australia,there are some Schedule 3 medications that can be advertised in the popular media.One example of a medication to which this advertising policy applies is:
A) miconazole pessaries.
B) ampicillin capsules.
C) royal jelly preparations.
D) codeine tablets.
A) miconazole pessaries.
B) ampicillin capsules.
C) royal jelly preparations.
D) codeine tablets.
miconazole pessaries.
3
The brand name of a medication is provided by the:
A) government.
B) pharmaceutical company.
C) biochemical scientist who invented the medication.
D) drug evaluation committee that formally examines all data about medications.
A) government.
B) pharmaceutical company.
C) biochemical scientist who invented the medication.
D) drug evaluation committee that formally examines all data about medications.
pharmaceutical company.
4
Which of the following acne preparations CANNOT be purchased as an over-the-counter preparation?
A) An isotretinoin preparation
B) A sulphur preparation
C) A resorcinol preparation
D) A benzoyl peroxide preparation
A) An isotretinoin preparation
B) A sulphur preparation
C) A resorcinol preparation
D) A benzoyl peroxide preparation
Unlock Deck
Unlock for access to all 12 flashcards in this deck.
Unlock Deck
k this deck
5
Why is once-daily dosing preferred for Australian Indigenous peoples?
A) Because Indigenous people generally have a poor memory.
B) Indigenous people have a culturally different concept of time, therefore minimising the number of doses is aimed at promoting compliance.
C) Because once-daily dosing is less likely to cause side effects such as renal disease.
D) All of the above.
A) Because Indigenous people generally have a poor memory.
B) Indigenous people have a culturally different concept of time, therefore minimising the number of doses is aimed at promoting compliance.
C) Because once-daily dosing is less likely to cause side effects such as renal disease.
D) All of the above.
Unlock Deck
Unlock for access to all 12 flashcards in this deck.
Unlock Deck
k this deck
6
It is best to learn about pharmacology with reference to what particular type of medication names?
A) Chemical names
B) Brand names
C) Generic names
D) Proprietary names
A) Chemical names
B) Brand names
C) Generic names
D) Proprietary names
Unlock Deck
Unlock for access to all 12 flashcards in this deck.
Unlock Deck
k this deck
7
For clients from culturally and linguistically diverse backgrounds,the health professional should assess
A) the client's beliefs and values.
B) self-treatment by home remedies or concurrent use of traditional medicines with conventional medicines.
C) concerns about drug therapy and/or invasive procedures.
D) all of the above.
A) the client's beliefs and values.
B) self-treatment by home remedies or concurrent use of traditional medicines with conventional medicines.
C) concerns about drug therapy and/or invasive procedures.
D) all of the above.
Unlock Deck
Unlock for access to all 12 flashcards in this deck.
Unlock Deck
k this deck
8
What is the potential problem with bioequivalence between different brand names of medications?
A) The colours of the preparations may be different.
B) The labels on the containers may be different.
C) Consumers may get confused about the availability of more than one preparation.
D) The medications may not be absorbed or act in the same way after administration.
A) The colours of the preparations may be different.
B) The labels on the containers may be different.
C) Consumers may get confused about the availability of more than one preparation.
D) The medications may not be absorbed or act in the same way after administration.
Unlock Deck
Unlock for access to all 12 flashcards in this deck.
Unlock Deck
k this deck
9
Patients taking OTC and complementary medication may:
A) have adverse drug interactions if they are also taking prescription medications.
B) not discuss the OTC or complementary medicines with their health professional as they do not consider them important.
C) attempt self-diagnosis and treatment prior to consulting their professional.
D) all of the above.
A) have adverse drug interactions if they are also taking prescription medications.
B) not discuss the OTC or complementary medicines with their health professional as they do not consider them important.
C) attempt self-diagnosis and treatment prior to consulting their professional.
D) all of the above.
Unlock Deck
Unlock for access to all 12 flashcards in this deck.
Unlock Deck
k this deck
10
A key feature of polypharmacy is:
A) self-diagnosing and medicating.
B) using many different pharmacies to purchase medicines.
C) the excessive or unnecessary use of medicines.
D) a reluctance to use complementary therapies.
A) self-diagnosing and medicating.
B) using many different pharmacies to purchase medicines.
C) the excessive or unnecessary use of medicines.
D) a reluctance to use complementary therapies.
Unlock Deck
Unlock for access to all 12 flashcards in this deck.
Unlock Deck
k this deck
11
The generic name of a medication is the:
A) name given by the biochemical scientist who invented the medication.
B) name given to the pharmaceutical company that manufactures the medication.
C) chemical name of the medication.
D) shortened, simplified version of the chemical name.
A) name given by the biochemical scientist who invented the medication.
B) name given to the pharmaceutical company that manufactures the medication.
C) chemical name of the medication.
D) shortened, simplified version of the chemical name.
Unlock Deck
Unlock for access to all 12 flashcards in this deck.
Unlock Deck
k this deck
12
What is meant by the term 'de facto direct-to-consumer advertising'?
A) When a professional pharmacy body advertises in a popular magazine about a particular medicine.
B) When a professional nursing body advertises in a nursing journal about a particular medicine.
C) When a pharmaceutical company provides information about specific characteristics of a particular medication in the popular media but does not mention the name of the medication.
D) When a professional pharmacy body provides information about specific characteristics of a particular medication in the popular media but does not mention the name of the medication.
A) When a professional pharmacy body advertises in a popular magazine about a particular medicine.
B) When a professional nursing body advertises in a nursing journal about a particular medicine.
C) When a pharmaceutical company provides information about specific characteristics of a particular medication in the popular media but does not mention the name of the medication.
D) When a professional pharmacy body provides information about specific characteristics of a particular medication in the popular media but does not mention the name of the medication.
Unlock Deck
Unlock for access to all 12 flashcards in this deck.
Unlock Deck
k this deck